Ontamalimab Usage And Synthesis

Uses

Ontamalimab (SHP647) is a fully-human IgG2 monoclonal antibody targeting mucosal addressin cell adhesion molecule-1 (MAdCAM-1). Ontamalimab can be used for the research of Crohn's disease[1].

References

[1] D'Haens GR, et, al. Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study. Inflamm Bowel Dis. 2022 Jul 1;28(7):1034-1044. DOI:10.1093/ibd/izab215

Ontamalimab(2098790-40-8)Related Product Information

• Zalifrelimab
• Galegenimab
• Tozorakimab
• Mezagitamab
• Befovacimab
• Tregalizumab
• Rinucumab
• Praluzatamab
• Tarextumab
• Gatipotuzumab